Best Brand-Name Tirzepatide (Mounjaro & Zepbound) Providers — Ranked & Reviewed
Brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management) are FDA-approved tirzepatide products from Eli Lilly. These telehealth providers prescribe and ship them nationwide.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Methodology & sources
Providers in this variant are scored against our published six-factor rubric[1], then filtered to match the specific form shown in the page title. Brand-name Zepbound is separately FDA-approved for chronic weight management[2], and the Mounjaro label is maintained by the FDA for type 2 diabetes[3].
Published Phase 3 efficacy for tirzepatide (~20.9% mean weight loss at the 15 mg dose over 72 weeks) comes from the SURMOUNT-1 trial[4]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[5].
Quick Picks: Top 5
Detailed Reviews
GoodRx
Best for: self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. Offers self-pay discount pricing for brand-name GLP-1 medications — Foundayo (orforglipron) starting at $149/month and Zepbound KwikPen (tirzepatide) starting at $299/month — redeemable at 70,000+ pharmacies nationwide. Also operates GoodRx Care, a telehealth arm offering GLP-1 prescriptions with online visits starting at $39.
Score Breakdown
Vaylen
Best for: GLP-1-focused care with oral and injectable options across all 50 states
Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified. Licensed clinicians in all 50 states.
Score Breakdown
Effecty
Best for: nationwide compounded semaglutide with brand-name fallback
Effecty offers compounded GLP-1 injections ($160–$205/mo) plus brand-name Ozempic, Wegovy, Zepbound, and Mounjaro. LegitScript certified. Ships to all states nationwide. No membership fees.
Score Breakdown
Alloy
Best for: women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory
Alloy (myalloy.com) is a menopause-focused telehealth brand whose Weight Care program offers brand-name Zepbound (from $349/mo), brand-name Wegovy (from $199/mo), oral Wegovy (semaglutide pill), compounded semaglutide, compounded tirzepatide, and compounded liraglutide (from $80/mo). Initial consultation is $49 (separate from medication cost). All consulting doctors are certified by The Menopause Society. Available in 48 states (not Louisiana or Mississippi for the Weight Care program).
Score Breakdown
Navio MD
Best for: compounded tirzepatide with brand-name fallback across 48 states
NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo). LegitScript verified. Available in 48 states (not AL or MS). Same price at every dose. Also offers women's hormone optimization.
Score Breakdown
Trifecta Meal Delivery
Best for: prepared meal delivery for weight-loss calorie control
Trifecta is a prepared-meal delivery service positioned for weight loss, athletic performance, and clean-eating lifestyles. Programs include Clean Classic, Keto, Paleo, Vegan, Vegetarian, and Whole30, with each meal portion-controlled and macro-tracked. Listed here as a weight-loss program adjunct that pairs well with calorie-deficit goals from GLP-1 therapy or standalone behavioral programs.
Score Breakdown
altRX
Best for: Buyers who want the broadest possible brand-name FDA-approved GLP-1 access on a single platform — altRX is the only provider in the WLR directory offering all four (Mounjaro / Ozempic / Wegovy / Zepbound) alongside compounded options. Strong fit for patients who may switch between compounded and brand-name depending on response, supply, or insurance situation.
altRX (altrx.com) is a dual-modality telehealth platform offering both compounded GLP-1 and all four brand-name FDA-approved GLP-1 medications — Mounjaro®, Ozempic®, Wegovy®, AND Zepbound® — which is the most comprehensive brand-name access in the WLR directory (most dual-modality competitors offer 1-2 brand-name options). Corporate structure: 'CareGLP Affiliated P.C.s' (Professional Corporations) + CareValidate Health (affiliated telemedicine network). LegitScript Certified ID 48475686 (verifiable). Verbatim FDA disclaimer: 'Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required.' Pricing: GLP-1 (compounded) starting at $149; GLP-1/GIP (compounded tirzepatide) starting at $249; Ozempic® $1,149; Mounjaro® $1,249; Zepbound® $1,249; Wegovy® $1,579. Pricing INCLUDES 'consult, prescription process, and shipping/delivery.' Approval 'In 1 day' framing. 'Get Upto $140 Off Today' promotional pricing. Telemedicine network: CareValidate Health. 'Compounded GLP-1s are produced in FDA-regulated facilities' (503A vs 503B not specified). Cancel anytime. Multiple USA-certified pharmacies (not named individually). 4.4-star rating 'Based on thousands of happy clients' (per site claim). NOT disclosed publicly: states-served list, specific pharmacy partner names, named medical director, governing law, corporate physical address. Live-verified 2026-05-20.
Score Breakdown
Buoy
Best for: GLP-1-companion electrolyte supplement
Buoy (justaddbuoy.com) is a liquid electrolyte drop with 87+ trace minerals, vitamins, and antioxidants from an ocean-electrolyte and whole-food base. Buoy markets itself as a general hydration and electrolyte product, NOT as a weight-loss or GLP-1-specific product — we list it here because electrolyte loss is a documented side effect of rapid GLP-1-mediated weight loss, but readers should know the GLP-1 framing is editorial, not the brand's own primary positioning.
Score Breakdown
Gruns Greens
Best for: daily-multivitamin gummy as a GLP-1 nutrition adjunct
Gruns is a daily greens gummy positioned as a more palatable alternative to powdered greens and traditional multivitamins. Marketed as a nutrition-density tool that pairs with weight-loss diets and GLP-1 therapy to maintain micronutrient intake when overall food intake drops.
Score Breakdown
Eve
Best for: Women seeking a women's-health-focused GLP-1 telehealth platform with dual access to either affordable compounded GLP-1 ($195/mo) OR brand-name FDA-approved Ozempic / Wegovy / Mounjaro ($1,399-$1,699/mo cash-pay), with LegitScript verification and a satisfaction guarantee. Strong fit for buyers who want a single platform supporting both ends of the compounded-vs-brand-name choice without switching providers.
Eve (tryeve.co) is a women's-health-focused GLP-1 telehealth platform — distinctive positioning vs the male-default DTC market. Tagline: 'Empowering Women's Health.' DUAL-MODALITY OFFERING (rare in the WLR directory — only Brightmeds + Eve offer both): compounded semaglutide $195/month (injection + oral sublingual forms), compounded tirzepatide $195/month, PLUS brand-name FDA-approved Ozempic® $1,399/month, Mounjaro® $1,399/month, Wegovy® $1,699/month. Payment model: 'You pay $0 unless approved by a licensed physician.' Free shipping on orders above $50. Satisfaction guarantee: 'We're confident you'll love it—or your money back.' Subscription cancelable anytime. LegitScript Certified with verifiable ID 42862417. Verbatim FDA disclaimer published: 'The FDA does not review or approve any compounded medications for safety or effectiveness.' Multi-state coverage implied (verbatim: 'If you relocate to a state we currently serve, your treatment can continue seamlessly') but explicit states list NOT disclosed. Pharmacy partner, 503A vs 503B designation, named medical director, corporate legal entity, and governing law are NOT publicly disclosed. Live-verified 2026-05-19.
Score Breakdown
HeliMeds
Best for: affordable compounded semaglutide with brand-name fallback options
HeliMeds offers compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound. LegitScript certified (#368688). Also provides sexual health and energy treatments.
Score Breakdown
IM8 Health
Best for: all-in-one daily greens-and-vitamin blend with independent third-party (NSF) quality testing
IM8 Health is a daily health drink and supplement system co-founded by David Beckham and Prenetics CEO Danny Yeung, positioning itself as an all-in-one greens, prebiotic, probiotic, vitamin, mineral, and adaptogen blend. Marketed for energy, gut health, longevity, and metabolic support. Distributed in the US by Prenetics Global Limited.
Score Breakdown
NowPatient
Best for: Brand-name GLP-1 access without a compounded route
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Consultations are free and patients pay only the cost of the prescribed medication, which means out-of-pocket tracks brand list prices (~$1,000-$1,350/mo without insurance). HQ Austin, TX.
Score Breakdown
fatty15
Best for: single-ingredient C15:0 longevity supplement
fatty15 is a daily C15:0 (pentadecanoic acid) supplement marketed for cellular longevity, metabolic health, and inflammation reduction. C15:0 is an odd-chain saturated fatty acid that the company's published research positions as the first essential fatty acid to be discovered in 90+ years, with claimed effects on cell membrane stability and mitochondrial function.
Score Breakdown
Form Health
Best for: comprehensive concierge care
Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.
Score Breakdown
Ark Health
Best for: Buyers seeking the broadest single-platform product menu (compounded + brand + non-GLP-1 wellness adjuncts like Sermorelin and MIC/B12 all under one account) who can tolerate the transparency gaps (no states list, no LegitScript ID, no named pharmacy partner). NOT recommended for buyers seeking brand Ozempic/Mounjaro — direct manufacturer channels (NovoCare, LillyDirect) are 2-3× cheaper. Best value tier is the compounded oral sema at $125/mo. Note: states-served gap means buyers should call (855) 758-2275 to confirm coverage before signing up.
Ark Health (tryark.com) is a national direct-to-consumer GLP-1 telehealth platform offering an unusually broad product menu — compounded semaglutide injection ($169/mo discounted), compounded tirzepatide injection ($249/mo discounted), compounded oral semaglutide ($125/mo discounted), brand Ozempic ($1,399/mo cash), brand Mounjaro ($1,499/mo cash), plus injectable Sermorelin ($220/mo) and injectable MIC/B12 ($220/mo). Brand cash pricing is significantly higher than direct pharmacy/coupon channels — DTC brand pricing through Ark Health is NOT competitive with NovoCare or LillyDirect. Compounded tier is the value play. '100% online consultations with certified healthcare providers' — sync vs async not explicitly stated. Verbatim marketing claims: 'Free expedited shipping,' 'Consistent pricing at all dosages,' 'No hidden fees,' 'Continuous support and follow-ups.' Phone: (855) 758-2275. Email: support@tryark.com. Significant gaps in public disclosure: states served NOT enumerated, LegitScript certification ID NOT visible, verbatim FDA compounded-medication disclaimer NOT displayed on homepage/FAQ, named medical director NOT disclosed, pharmacy partner (503A/503B) NOT named, HSA/FSA eligibility NOT confirmed, corporate legal entity NOT specified, corporate address NOT provided, refund/cancellation policy linked but text not surfaced on browseable pages. Live-verified 2026-05-20.
Score Breakdown
Frequently Asked Questions
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 3.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 4.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 5.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.